Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-09-16
2000-03-07
Clardy, S. Mark
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514255, 514254, 514253, 544224, 544336, 544358, 544359, 544360, 544361, A61K 31495, A61K 3150, C07D40300, C07D40100
Patent
active
06034086&
ABSTRACT:
This invention relates to a 8-trifluoromethylquinolinecaboxylic acid derivative represented by the following formula (I): ##STR1## (wherein R.sup.1 represents a lower alkyl group, a halogeno-lower alkyl group or a cycloalkyl group, R.sup.2 represents a phenyl group which may be substituted by R.sup.0, a 5-membered or 6-membered aromatic heteromonocyclic ring group containing 1 or 2 hetero atoms selected from N, O and S, which may be substituted by R.sup.0, or an aromatic heterocyclic fused ring group in which the said aromatic heteromonocyclic ring group and a benzene ring are fused, R.sup.0 represents a group selected from a halogen, a lower alkyl, a fluorine-substituted lower alkyl, a lower alkoxy or a lower alkylthio, R.sup.3 represents hydrogen or a lower alkyl group, and m represents an integer of 2 or 3.) or a pharmaceutically acceptable salt thereof or an ester thereof.
REFERENCES:
patent: 4448962 (1984-05-01), Irkura et al.
patent: 4544658 (1985-10-01), Petersen et al.
patent: 4556658 (1985-12-01), Grohe et al.
patent: 4563459 (1986-01-01), Grohe et al.
patent: 4588726 (1986-05-01), Petersen et al.
patent: 4668680 (1987-05-01), Trehan et al.
patent: 4705788 (1987-11-01), Schriewer et al.
patent: 4780468 (1988-10-01), Bridges et al.
patent: 4822801 (1989-04-01), Domagala et al.
patent: 4851418 (1989-07-01), Sanchez
patent: 5221676 (1993-06-01), Laborde et al.
patent: 5519016 (1996-05-01), Kimura et al.
patent: 5587386 (1996-12-01), Hayakawa et al.
Suto, Mark, et al., "Eluoroquinolones: Relationships between Structural Variations, Mammalian Cell Cytotoxicity, and Antimicrobial Activity", J. Med. Chem., 35, 4745-4750 (1992).
Junko Nozaki-Renard et al., "A Fluoroquinolone (DR-3355) Protects Human Lymphocyte Cell Lines From HIV-1-Induced Cytotoxicity", Aids, 4, 1283-1286 (1990).
Sanchez et al., J. Med. Chem., (1992), vol. 35, No. (2), pp. 361-367.
Klopman et al., J. Med. Chem., (1993), vol. 37, No. (12), p. 2766.
Renau et al., Antimicrob. Agents Chemother., (1996), vol. 40, No. (10), pp. 2363-2368.
Suto et al., J. Med. Chem., (1992), vol. 35, No. (25), pp. 4745-4750.
Katsube Tetsushi
Kimura Tomio
Nishigaki Takashi
Clardy S. Mark
Qazi Sabiha N.
Sankyo Company Limited
Ube Industries Ltd.
LandOfFree
Trifluoromethylquinolinecarboxylic acid derivative does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Trifluoromethylquinolinecarboxylic acid derivative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Trifluoromethylquinolinecarboxylic acid derivative will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-363358